{"id":"NCT01921205","sponsor":"UCB Pharma","briefTitle":"Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures","officialTitle":"A Multicenter, Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy ≥4 Years to <17 Years of Age With Partial Onset Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08-29","primaryCompletion":"2017-01-24","completion":"2017-01-24","firstPosted":"2013-08-13","resultsPosted":"2018-03-19","lastUpdate":"2018-07-18"},"enrollment":404,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy"],"interventions":[{"type":"DRUG","name":"Lacosamide","otherNames":["Vimpat(R)"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Lacosamide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Study to evaluate the efficacy of Lacosamide (LCM) administered in addition to 1 to ≤3 other Anti-Epileptic Drugs in subjects with epilepsy ≥4 years to \\<17 years of age who currently have uncontrolled partial onset seizures.","primaryOutcome":{"measure":"Change in Partial Onset Seizure (POS) Frequency Per 28 Days From Baseline to the Maintenance Period","timeFrame":"Baseline to Week 16 (or last value on treatment)","effectByArm":[{"arm":"Placebo (FAS)","deltaMin":-1.55,"sd":null},{"arm":"Lacosamide (FAS)","deltaMin":-3.05,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.0003"}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":22},"locations":{"siteCount":118,"countries":["United States","Argentina","Australia","Belgium","Bulgaria","Colombia","Croatia","Czechia","Estonia","Georgia","Hungary","Israel","Italy","Latvia","Lithuania","Mexico","Montenegro","Poland","Romania","Russia","Serbia","Slovakia","Slovenia","South Korea","Taiwan","Thailand","Ukraine","United Kingdom"]},"refs":{"pmids":["34033237","33998660","31462582"],"seeAlso":["http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":172},"commonTop":["Somnolence","Dizziness","Nasopharyngitis","Headache","Vomiting"]}}